Sharks
Novavax slid nearly 20% in morning trading as the company was facing issues with the purity of its vaccine candidate
Novavax slid nearly 20% in morning trading as the company was facing issues with the purity of its v
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
4
举报
登录后可参与评论
暂无评论